Tuberculosis (TB) is a highly infectious disease caused by bacteria that spread easily in the air (e.g., through coughing and sneezing). TB usually infects the lungs but can also affect other parts of the body, such as the lymph nodes, urinary tract, and bones. While the overall number of TB cases in Canada is low, there are significant disparities in TB prevalence among geographic regions and populations. Timely diagnosis and treatment of patients who have active disease is critical for reducing TB transmission.
CADTH, in consultation with its customers, is undertaking a Condition Level Review on TB. A Condition Level Review is an assessment of the evidence on a range of health technologies and emerging issues on all aspects of the condition, including prevention, identification, treatment, and management.
On this page, you will find the completed reports and information on reports that are currently underway and/or planned for completion. You can also find related tools and resources from CADTH and other organizations that are doing work in this area. The bundle will be updated as CADTH’s work on the topic progresses.
We have selected the following materials to get you started:
- Condition-Level Review Project Plan on Tuberculosis (Project Plan, July 2020)
- Tuberculosis in People with Compromised Immunity: A Review of Guidelines (Summary with Critical Appraisal, March 2020)
- Drug-Resistant Tuberculosis: A Review of the Guidelines (Summary with Critical Appraisal, March 2020)
- Treatment of Tuberculosis: A Review of Guidelines (Summary with Critical Appraisal, March 2020)
- Identification of Tuberculosis: A Review of the Guidelines (Summary with Critical Appraisal, February 2020)
- Prevention of Tuberculosis: A Review of Guidelines (Summary with Critical Appraisal, January 2020)
- Monitoring tuberculosis treatment by video: Might convenience increase compliance? (Hospital News Article, April 2019)